Published in Biochem Biophys Res Commun on June 07, 1999
SCPRED: accurate prediction of protein structural class for sequences of twilight-zone similarity with predicting sequences. BMC Bioinformatics (2008) 1.01
iNR-Drug: predicting the interaction of drugs with nuclear receptors in cellular networking. Int J Mol Sci (2014) 0.96
Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs. PLoS One (2011) 0.95
Modular prediction of protein structural classes from sequences of twilight-zone identity with predicting sequences. BMC Bioinformatics (2009) 0.93
CDK5 activator protein p25 preferentially binds and activates GSK3β. Proc Natl Acad Sci U S A (2014) 0.89
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method. PLoS One (2011) 0.88
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach. PLoS One (2012) 0.88
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics. Drug Des Devel Ther (2013) 0.85
iROS-gPseKNC: Predicting replication origin sites in DNA by incorporating dinucleotide position-specific propensity into general pseudo nucleotide composition. Oncotarget (2016) 0.82
Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein. J Mol Model (2010) 0.77
Bioassay directed isolation and biological evaluation of compounds isolated from Rubus fairholmianus Gard. Biomed Res Int (2014) 0.77
Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations. PLoS One (2012) 0.75
Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity. Oncotarget (2017) 0.75
Macromolecular Crystallographic Information File. Methods Enzymol (1997) 11.94
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85
Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48
Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80
NH---S hydrogen bonds in Peptococcus aerogenes ferredoxin, Clostridium pasteurianum rubredoxin, and Chromatium high potential iron protein. Proc Natl Acad Sci U S A (1975) 1.91
Cation binding to the integrin CD11b I domain and activation model assessment. Structure (1998) 1.90
Water structure in a protein crystal: rubredoxin at 1.2 A resolution. J Mol Biol (1978) 1.89
Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution. J Mol Biol (1980) 1.85
Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem (1977) 1.81
Nucleotide sequence and expression of the capsid protein gene of feline calicivirus. J Virol (1991) 1.78
The structure of a non-heme iron protein: rubredoxin at 1.5 Angstrom resolution. Cold Spring Harb Symp Quant Biol (1972) 1.67
The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem (1992) 1.63
A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J Biol Chem (1991) 1.59
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56
The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure (1999) 1.54
Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52
Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry (1991) 1.48
Structure of the oxidized form of a flavodoxin at 2.5-Angstrom resolution: resolution of the phase ambiguity by anomalous scattering. Proc Natl Acad Sci U S A (1972) 1.47
Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution. J Mol Biol (1989) 1.46
Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J Mol Biol (1991) 1.44
The selective S-methylation of sulfhydryl groups in proteins and peptides with methyl-p-nitrobenzenesulfonate. J Biol Chem (1971) 1.41
The covalent and tertiary structure of bovine liver rhodanese. Nature (1978) 1.41
A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem (1984) 1.38
The structure of rubredoxin at 1.2 A resolution. J Mol Biol (1979) 1.38
Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1982) 1.37
Sequence of the bacteriophage SP01 gene coding for transcription factor 1, a viral homologue of the bacterial type II DNA-binding proteins. Proc Natl Acad Sci U S A (1984) 1.36
Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem (1990) 1.32
Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J Biol Chem (1991) 1.29
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem (1998) 1.29
Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J Biol Chem (1990) 1.29
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease. Biochemistry (1990) 1.26
The binding of riboflavin-5'-phosphate in a flavoprotein: flavodoxin at 2.0-Angstrom resolution. Proc Natl Acad Sci U S A (1973) 1.26
Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1996) 1.24
Active site cysteinyl and arginyl residues of rhodanese. A novel formation of disulfide bonds in the active site promoted by phenylglyoxal. J Biol Chem (1978) 1.24
Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene (1990) 1.24
Applications of thermolysin in protein structural analysis. Methods Enzymol (1977) 1.22
The covalent protein structure of insecticyanin, a blue biliprotein from the hemolymph of the tobacco hornworm, Manduca sexta L. J Biol Chem (1984) 1.21
Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol (1999) 1.21
Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method. Proteins (1996) 1.20
Purification, physical characterization, and NH2-terminal sequence of glutamine synthetase from the cyanobacterium Anabaena 7120. J Biol Chem (1981) 1.18
Purification and properties of methionyl-transfer-ribonucleic acid synthetase from Escherichia coli. Biochem J (1967) 1.18
Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. J Biol Chem (1991) 1.16
Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem (1999) 1.16
Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies. J Protein Chem (1993) 1.14
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Protein Sci (1992) 1.13
Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol (1993) 1.13
Silkmoth chorion proteins. Their diversity, amino acid composition, and the NH-terminal sequence of one component. J Biol Chem (1978) 1.12
Detection and kinetic behavior of preproinsulin in pancreatic islets. Proc Natl Acad Sci U S A (1978) 1.12
Anthranilate synthetase component II from Pseudomonas putida. Covalent structure and identification of the cysteine residue involved in catalysis. J Biol Chem (1978) 1.12
Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry (1986) 1.11
Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1994) 1.09
Purification and characterization of a low molecular weight acid phosphatase from bovine liver. J Biol Chem (1969) 1.09
Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease. J Biol Chem (1992) 1.08
The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism. J Biol Chem (2001) 1.08
CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem (1995) 1.07
Covalent structural analysis of yeast inorganic pyrophosphatase. J Biol Chem (1978) 1.07
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. J Med Chem (1997) 1.06
On the alkylation of amino acid residues at the active site of ribonuclease. J Biol Chem (1966) 1.04
Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates. Methods Enzymol (1994) 1.03
Targeting the HIV-protease in AIDS therapy: a current clinical perspective. Biochim Biophys Acta (2000) 1.03
Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. J Biol Chem (1990) 1.03
Chloroplast and cytoplasmic enzymes 1, 2, 3. Subunit structure of pea leaf aldolases. Arch Biochem Biophys (1975) 1.01
The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. J Biol Chem (1993) 1.01
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. Protein Sci (1993) 0.99
Phosphorylation of rat hepatic fructose-1,6-bisphosphatase and pyruvate kinase. J Biol Chem (1980) 0.98
HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res Hum Retroviruses (1992) 0.97
Sequence analysis of bovine lens aldose reductase. J Biol Chem (1990) 0.97
Using pair-coupled amino acid composition to predict protein secondary structure content. J Protein Chem (1999) 0.96
Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. Biochemistry (1991) 0.96
The amino acid sequence of a testis-specific basic protein that is associated with spermatogenesis. J Biol Chem (1975) 0.96
The chemical basis for interfacial activation of monomeric phospholipases A2. Autocatalytic derivatization of the enzyme by acyl transfer from substrate. J Biol Chem (1988) 0.95
The covalent structure of bovine liver rhodanese. Isolation and partial structural analysis of cyanogen bromide fragements and the complete sequence of the enzyme. J Biol Chem (1978) 0.94
The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution. J Biol Chem (1990) 0.94
Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils. Biochim Biophys Acta (1987) 0.93
The biochemistry of pseudouridine. Prog Nucleic Acid Res Mol Biol (1966) 0.92
The lysine-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to other phospholipases A2. J Biol Chem (1986) 0.92
Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression. Proteolytic processing and protease inhibitory properties. J Biol Chem (1991) 0.92
Postsynthetic modification of high mobility group proteins. Evidence that high mobility group proteins are acetylated. J Biol Chem (1978) 0.91
Dissection and sequence analysis of phospholipases A2. Methods Enzymol (1991) 0.91
Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity. J Med Chem (1991) 0.91
Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis. Biochim Biophys Acta (1977) 0.91
Dimerization and activation of porcine pancreatic phospholipase A2 via substrate level acylation of lysine 56. J Biol Chem (1989) 0.90
Chloroplast and cytoplasmic enzymes: isolation and sequencing of cDNAs coding for two distinct pea chloroplast aldolases. Arch Biochem Biophys (1992) 0.89
Isolation of an active-site peptide of lipoprotein lipase from bovine milk and determination of its amino acid sequence. J Biol Chem (1986) 0.89
Amino acid sequence of the COOH-terminal region of fructose-1,6-bisphosphatases in relation to cyclic AMP-dependent phosphorylation. J Biol Chem (1983) 0.88
The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases. J Biol Chem (1995) 0.87
Evidence for the presence of a carbohydrate moiety in fluorescein isothiocyanate labeled fragments of rat gastric (H+-K+)-ATPase. Biochemistry (1989) 0.87
Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the beta amyloid protein region. Biochemistry (1992) 0.87
The covalent structure of pig kidney fructose 1,6-bisphosphatase: sequence of the 60-residue NH2-terminal peptide produced by digestion with subtilisin. Arch Biochem Biophys (1981) 0.87
The amino acid sequence in the vicinity of the covalently bound adenylic acid in glutamine synthetase from Escherichia coli. J Biol Chem (1970) 0.87
Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2. Proteins (1991) 0.86
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors. J Med Chem (1996) 0.86